| Systematic (IUPAC) name | |
|---|---|
| 1,3,4,6-tetrakis-O-(pyridin-3-ylcarbonyl)-β-D-fructofuranose | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| ATC code | C10AD03 |
| PubChem | CID 25495 |
| UNII | GF99P6327K |
| KEGG | D07189 |
| Chemical data | |
| Formula | C30H24N4O10 |
| Mol. mass | 600.533 g/mol |
| |
|
Nicofuranose is a niacin derivative used as a hypolipidemic agent.
|
||||||||||||||||||||||||||||||||||||||||
| This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)